DeCODE Genetics
deCODE genetics ( Icelandic Íslensk erfðagreining ) is an Icelandic company based in Reykjavík .
Companies
The company was founded in 1996 by Kári Stefánsson , among others , to use population-based studies to identify genes that have an impact on common diseases.
Business area
The company is in charge of the genetic testing of the population of Iceland using blood and tissue samples, family trees and medical records . Hoffmann-La Roche acquired the rights to use the results in February 1998 for US $ 200 million .
In December 1998 the Icelandic parliament Althing decided that this company would collect and store all health data of the population across the board. The legal basis in Iceland is the Act on Biobanks . The highest court in Hæstiréttur ruled in 2003 that this law was not constitutional because it subsequently violated the privacy of the deceased, and that the encryption of the data was insufficient.
In November 2009, the company announced that it had filed for Chapter 11 bankruptcy in the US and was selling its core business to US investors.
A full scan cost $ 1,100 in September 2012.
In December 2012, deCODE Genetics was acquired by Amgen for $ 415 million .
Competitor
In the area of private genetic analysis, the US companies 23andMe and Navigenics are competitors, with Navigenics now being sold to Life Technologies .
Individual evidence
- ↑ decode.com: Management
- ↑ Press release from deCODE Genetics
- ↑ Archive link ( Memento of the original from October 6, 2012 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. , October 1, 2012
- ↑ Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics. Retrieved January 27, 2017 (English).
Web links
- DeCODE Genetics website
- Decode Human Genetics ( Memento of July 6, 2007 in the Internet Archive ) (in the Internet Archive )